6.1 Schedule II Prescriptions, 60-Day Validity & 3-Day Limit

6.1 Schedule II Prescriptions, 60-Day Validity & 3-Day Limit

Schedule II (C-II) controlled substances represent the highest tier of medications with approved medical use and possess significant potential for severe psychological or physical dependence and abuse. Consequently, both federal statute (the Controlled Substances Act) and Kentucky law (KRS Chapter 218A and Title 201 KAR Chapter 2) subject Schedule II medications to the most stringent dispensing, documentation, and operational constraints in pharmacy practice.

---

1. Schedule II Prescriptions: Core Federal & Kentucky Requirements

To be valid for dispensing, a Schedule II prescription must satisfy rigorous formal requirements established by both the DEA and the Commonwealth of Kentucky:

┌─────────────────────────────────────────────────────────────────────────────┐
│                 SCHEDULE II MANDATORY PRESCRIPTION ELEMENTS                │
├─────────────────────────────────────────────────────────────────────────────┤
│ • Full patient name and residential address                                 │
│ • Prescriber full name, professional address, and DEA registration number   │
│ • Drug name, strength, dosage form, and quantity prescribed                 │
│ • Specific directions for use (Sig) and refill indicator (must be ZERO)     │
│ • Date of issuance (must reflect the actual date signed/transmitted)        │
│ • Prescriber manual signature (wet signature on paper) or valid EPCS cert   │
│ • Written prescriptions in KY MUST be on Kentucky Security Blank            │
└─────────────────────────────────────────────────────────────────────────────┘

Absolute Prohibition of Refills

Under Section 309(a) of the Controlled Substances Act (21 U.S.C. § 829) and KRS 218A.180(1), no prescription for a Schedule II controlled substance may be refilled under any circumstances. If a patient requires additional medication, the practitioner must issue a brand-new prescription that independently satisfies all legal requirements.

Form of Prescription & Transmission Methods

1. Electronic Prescribing (EPCS): Controlled substance prescriptions in Kentucky must be transmitted electronically via DEA-compliant software (KRS 218A.182), unless a specific statutory exemption applies (e.g., technological failure, out-of-state prescriber, emergency situation, hospice/nursing home).
2. Written Prescriptions: When an exemption applies, written Schedule II prescriptions must be hand-signed with a wet signature and written on an official Kentucky Security Prescription Blank (902 KAR 55:105) featuring green watermark paper, opaque "RX" symbol, anti-copy pantograph, and pre-printed prescriber information.
3. Facsimile (Faxed) Prescriptions: A faxed Schedule II prescription generally serves only as an informational copy and cannot be dispensed until the original written, hand-signed prescription is presented. However, federal law (21 CFR § 1306.11) and Kentucky law recognize three narrow exceptions where the faxed copy serves as the original written prescription:
   • A Schedule II narcotic substance compounded for direct administration to a patient by parenteral, IV, IM, subcutaneous, or intraspinal infusion.
   • Any Schedule II substance for a resident of a Long-Term Care Facility (LTCF).
   • A Schedule II narcotic substance for a patient enrolled in a hospice care program certified by Medicare or licensed by the state (prescriber must annotate "hospice patient" on the prescription).

---

2. Prescription Validity: The Kentucky 60-Day Expiration Rule

A critical high-yield distinction between federal and Kentucky law centers on prescription expiration:

Exam Trap — Calculating the 60-Day Window: The 60-day validity window begins on the date of issuance (date written). Day 1 is the day following the date of issue. Even if a prescriber writes a future "Do not dispense before [date]" on the prescription, the 60-day expiration clock runs from the actual date of issue, NOT the future "do not dispense before" date. If day 60 arrives and the prescription has not been filled, it becomes legally void.

3. Kentucky 3-Day Acute Pain Opioid Limit (KRS 218A.205 / House Bill 333)

In response to the opioid epidemic, the Kentucky General Assembly enacted House Bill 333 (codified in KRS 218A.205), establishing a strict statutory limit on Schedule II opioid prescriptions prescribed for acute pain.

Definition of "Acute Pain"

Under KRS 218A.205, acute pain is defined as pain that results from disease, injury, or a medical/surgical procedure, with an anticipated brief duration that does not exceed the normal course of healing (typically pain persisting for less than 3 months).

The 3-Day Prescribing Limitation

A practitioner licensed in Kentucky shall not issue a prescription for a Schedule II controlled substance that is an opioid for more than a 3-day supply when intended to treat acute pain.

The Five Statutory Exceptions to the 3-Day Cap

A prescriber may exceed the 3-day supply limitation for a Schedule II opioid ONLY if the patient meets one of the following five statutory exceptions:

1. Chronic Pain: Pain persisting for more than 3 months or extending beyond the expected period of tissue healing.
2. Cancer-Related Pain: Pain associated with an active malignancy or cancer treatment.
3. Hospice, End-of-Life, or Palliative Care: Pain experienced by a patient diagnosed with a terminal illness or receiving palliative care services.
4. Inpatient Administration: Opioids administered directly to an inpatient in a hospital, long-term care facility, nursing home, or ambulatory surgical center.
5. Major Surgery or Extensive Trauma: A prescriber may prescribe more than a 3-day supply if, in their professional clinical judgment, a greater quantity is medically necessary, provided the prescriber documents the clinical justification in the patient's medical record.

┌─────────────────────────────────────────────────────────────────────────────┐
│               KRS 218A.205 ACUTE PAIN 3-DAY LIMIT AT A GLANCE               │
├──────────────────────────┬──────────────────────────────────────────────────┤
│ Regulated Substances     │ Schedule II Opioids ONLY (e.g., oxycodone,       │
│                          │ hydrocodone, morphine, hydromorphone, fentanyl). │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ Non-Opioid Controls      │ Schedule II Stimulants (Adderall, Ritalin) are    │
│                          │ NOT subject to the 3-day acute pain cap.         │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ General Acute Limit      │ Maximum 3-day supply.                            │
├──────────────────────────┼──────────────────────────────────────────────────┤
│ 5 Statutory Exceptions   │ 1. Chronic Pain                                  │
│                          │ 2. Cancer Pain                                   │
│                          │ 3. Hospice / Palliative / End-of-Life Care       │
│                          │ 4. Inpatient Administration                      │
│                          │ 5. Major Surgery / Trauma (Documented in Chart)  │
└──────────────────────────┴──────────────────────────────────────────────────┘

Pharmacist Corresponding Responsibility & Workflow

• Pharmacists are not legally expected to inspect the prescriber's private hospital or clinic medical charts.
• However, under corresponding responsibility (21 CFR § 1306.04 and KRS 218A.180), if an outpatient prescription clearly reflects an acute condition (e.g., acute dental extraction, acute ankle sprain, minor laceration) and is written for a 10-day or 30-day supply without an exception noted, the pharmacist cannot turn a blind eye.
• The pharmacist must communicate with the prescriber to confirm whether an exception applies (e.g., major surgical trauma) or obtain authorization to reduce the quantity to a compliant 3-day supply.

---

4. Emergency Oral Schedule II Dispensing

Under federal law (21 CFR § 1306.11(d)) and Kentucky law (KRS 218A.180), a pharmacist may dispense a Schedule II controlled substance pursuant to an oral authorization from a prescribing practitioner ONLY in a bona fide emergency situation.

The Three Statutory Emergency Criteria

An "emergency situation" exists only if the prescribing practitioner determines that:

1. Immediate administration of the Schedule II controlled substance is necessary for the proper treatment of the intended ultimate user;
2. No appropriate alternative treatment is available, including administration of a non-controlled drug or a controlled substance in Schedule III, IV, or V; and
3. It is not reasonably possible for the prescribing practitioner to provide a written prescription (or electronic prescription) prior to dispensing.

Dispensing Constraints for Oral Emergency Orders

• Quantity Limit: The quantity prescribed and dispensed must be limited strictly to the amount adequate to treat the patient during the emergency period. Dispensing a 30-day supply on an oral emergency order is illegal; the quantity must cover only the duration until a written/electronic order can be delivered (typically 24 to 72 hours).
• Immediate Reduction to Writing: The pharmacist must immediately reduce the oral prescription to writing. The written record must contain all information required for a Schedule II prescription, except for the prescriber's physical signature.

The 7-Day "Cover" Prescription Mandate

• Delivery Deadline: Within seven (7) days after authorizing an emergency oral prescription, the prescriber must deliver or postmark a written prescription, or transmit an EPCS prescription, to the dispensing pharmacy.
• Face Annotation: The cover prescription must have written on its face: "Authorization for Emergency Dispensing" and the date of the oral order.
• Attachment: Upon receipt, the dispensing pharmacist must attach this written cover prescription to the oral emergency prescription order previously reduced to writing (or annotate the electronic record).

┌─────────────────────────────────────────────────────────────────────────────┐
│               EMERGENCY ORAL C-II: 7-DAY ESCALATION PROTOCOL                │
├─────────────────────────────────────────────────────────────────────────────┤
│ Day 0: Emergency oral order received -> Dispense emergency quantity only    │
│        Pharmacist immediately reduces order to writing                      │
│                                                                             │
│ Day 1–7: Await written/electronic cover ('Authorization for Emergency       │
│          Dispensing' + date of oral order)                                  │
│                                                                             │
│ If Cover Received within 7 Days: Attach cover to oral order -> File closed  │
│                                                                             │
│ If Cover NOT Received within 7 Days:                                        │
│ └─> Pharmacist MUST notify:                                                 │
│     1. Local DEA Diversion Field Office (Federal mandate)                   │
│     2. Kentucky Cabinet for Health and Family Services (CHFS) / KBOP        │
│ └─> Failure to notify strips the dispensing of legal immunity, making the   │
│     pharmacist liable for unlawful C-II distribution!                       │
└─────────────────────────────────────────────────────────────────────────────┘

---

5. Schedule II Partial Dispensing: Three Distinct Legal Frameworks

Partial dispensing of Schedule II controlled substances is governed by three separate legal mechanisms depending on the underlying circumstance: (1) Inability to Supply (Stock-Out), (2) Terminally Ill / LTCF Patients, and (3) Patient / Prescriber Request under CARA 2016.

Framework 1: Inability to Supply / Out of Stock (21 CFR § 1306.13(a))

• Trigger: The pharmacy cannot supply the full quantity prescribed due to inventory stock-out.
• Documentation: The pharmacist must record the quantity dispensed on the face of the written prescription or electronic record.
• 72-Hour Completion Window: The remaining portion of the prescription must be filled within 72 hours of the first partial dispensing.
• Failure to Complete within 72 Hours: If the remaining portion is not or cannot be filled within the 72-hour window, the pharmacist must notify the prescribing practitioner, and the remaining balance becomes completely void. No further quantity may be dispensed after 72 hours without a new prescription.

Framework 2: Terminally Ill & LTCF Patients (21 CFR § 1306.13(b) & 902 KAR 55:095)

• Trigger: Prescriptions for patients in a Long-Term Care Facility (LTCF) or patients diagnosed with a terminal illness.
• Mandatory Annotation: The pharmacist must write "terminally ill" or "LTCF patient" on the prescription record. Dispensing partial fills without this exact annotation is a federal and state violation.
• 60-Day Validity Window: Partial fills are permitted for up to 60 days from the date of issuance (or until the total authorized quantity is exhausted, whichever occurs first).
• Dispensing Log: For each partial fill, the pharmacist must record: (1) date of partial dispensing, (2) quantity dispensed, (3) remaining quantity authorized to be dispensed, and (4) identification of the dispensing pharmacist.

Framework 3: Patient or Prescriber Requested under CARA 2016 (21 U.S.C. § 829(f))

• Trigger: The Comprehensive Addiction and Recovery Act (CARA) of 2016 amended the CSA to allow partial fills of Schedule II prescriptions upon the request of the patient or the prescribing practitioner (e.g., a patient wishes to take 5 tablets home after surgery to see if that controls the pain before paying for the remaining 25 tablets).
• 30-Day Window: The remaining portions of the partially filled Schedule II prescription must be filled within 30 days from the date the prescription was written (issued).
• Total Quantity Cap: The total quantity dispensed in all partial fills cannot exceed the total quantity prescribed.
• State Law Interaction: CARA partial fills are permissible provided they are not prohibited by state law (Kentucky law permits CARA-compliant partial dispensing within Kentucky's 60-day validity window, with the 30-day CARA clock governing the partial fill completion).

Comprehensive Schedule II Partial Fill Comparison Table

---

6. Sequential Schedule II Prescriptions (90-Day Supply Rule)

Under federal regulations (21 CFR § 1306.12) and Kentucky administrative standards, an individual practitioner may issue multiple Schedule II prescriptions on the same day authorizing a patient to receive a total of up to a 90-day supply, subject to strict safeguards:

┌─────────────────────────────────────────────────────────────────────────────┐
│                 SEQUENTIAL C-II PRESCRIPTIONS (90-DAY RULE)                 │
├─────────────────────────────────────────────────────────────────────────────┤
│ 1. Maximum Cumulative Supply: Total supply across all sequential orders     │
│    cannot exceed 90 days.                                                   │
│                                                                             │
│ 2. Date of Issuance: Each separate prescription must bear the ACTUAL date   │
│    on which it was signed/issued (NO POSTDATING PERMITTED).                 │
│                                                                             │
│ 3. Earliest Fill Date Instructions: Prescriptions intended to be filled     │
│    later must include explicit written instructions stating the earliest    │
│    date on which the pharmacy may dispense the medication:                  │
│    Example: 'Do not dispense before October 15, 2026'                       │
│                                                                             │
│ 4. No Early Dispensing: The pharmacist cannot dispense the medication prior │
│    to the designated 'Do not dispense before' date.                         │
│                                                                             │
│ 5. Legitimate Medical Purpose: The prescriber must conclude there is a      │
│    legitimate medical purpose and no undue risk of diversion.               │
└─────────────────────────────────────────────────────────────────────────────┘

Exam Trap — Postdating vs. Sequential Instructions: Writing a future date in the "Date Issued" field (postdating) is strictly illegal under both federal and Kentucky law. Every prescription must reflect the date it was actually signed. Future dispensing is authorized only by writing the true date of issue AND adding an explicit "Do not dispense before [future date]" instruction.